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ABSTRACT
Glomerular injury can involve excessive proliferation of glomerular epithelial cells, resulting in crescent
formation and obliteration of Bowman’s space. The origin of these hyperplastic epithelial cells in
different glomerular disorders is controversial. Renal progenitors localized to the inner surface of
Bowman’s capsule can regenerate podocytes, but whether dysregulated proliferation of these progen-
itors contributes to crescent formation is unknown. In this study, we used confocal microscopy, laser
capture microdissection, and real-time quantitative reverse transcriptase–PCR to demonstrate that
hypercellular lesions of different podocytopathies and crescentic glomerulonephritis consist of three
distinct populations: CD133CD24podocalyxin (PDX)nestin renal progenitors, CD133CD24
PDXnestin transitional cells, and CD133CD24PDXnestin differentiated podocytes. In addition,
TGF- induced CD133CD24 progenitors to produce extracellular matrix, and these were the only cells
to express the proliferation marker Ki67. Taken together, these results suggest that glomerular hyper-
plastic lesions derive from the proliferation of renal progenitors at different stages of their differentiation
toward mature podocytes, providing an explanation for the pathogenesis of hyperplastic lesions in
podocytopathies and crescentic glomerulonephritis.
J Am Soc Nephrol 20: 2593–2603, 2009. doi: 10.1681/ASN.2009020132
The traditional glomerular disease classification en-
compasses a bewildering array of descriptive patho-
logic entities and their clinical counterparts.1–10 Ev-
idence suggests that depending on the cause and
associated environmental factors, podocyte dys-
function or injury is a common factor underlying a
broad spectrum of histopathologic patterns in
which glomerular hyperplastic and/or sclerotic le-
sions are variably combined.3–10 In adult humans,
either delayed or excessive wound healing canman-
ifest in every injured epithelial tissue.11 Delayed
healing is the consequence of an insufficient re-
sponse of resident epithelial progenitor cells that
are thus replaced by extracellular matrix (ECM),
leading to fibrosis. Conversely, excessive healing is
characterized by aberrant progenitor cell prolifera-
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tion, referred to as hypertrophic scarring.11 In the glomerulus,
the response to podocyte injury can involve aberrant ECM
production and replacement of resident cells by areas of fibro-
sis, as described for the lesions found in patients with and ex-
perimental models of focal segmental glomerulosclerosis
(FSGS).2,6 Conversely, excessive proliferation of resident glo-
merular epithelium may cause (pseudo)crescent formation
and Bowman’s space obliteration, as seen in the hypercellular
lesions of collapsing glomerulopathy and in crescentic glomer-
ulonephritis.3,5,7–10
Recent studies have provided the first evidence that podo-
cytes can be regenerated from a resident population of renal
progenitors localized along the inner surface of the Bowman’s
capsule.12–16 In both humans and mice, these progenitors
reach the glomerular tuft via the vascular pole, where complete
differentiation into podocytes occurs.12–18 In humans, these
cells are characterized by the presence of surface CD133 and
CD24 and the expression of transcription factors Oct-4 and
BmI-1.12–16 More recently, we demonstrated that renal pro-
genitors are a heterogeneous population of cells that express
the stem cell markers CD133 and CD24 in the presence or
absence of podocyte-specific markers such as PDX or nes-
tin.16
In this study, we hypothesized that, as a consequence of
glomerular injury, resident renal progenitors of the Bowman’s
capsule proliferate in attempt to replace injured podocytes and
that if regeneration occurs in a dysregulated manner, then it
can generate hyperplastic glomerular lesions, scarring, and
eventually nephron loss. Hyperplastic lesions that are fre-
quently observed in glomerular disorders, particularly in col-
lapsing glomerulopathy and crescentic glomerulonephritis,
originate from CD133CD24 renal progenitors at different
stages of their differentiation toward mature podocytes. These
results might reconcile seemingly contradictory results of the
literature and suggest a novel intriguing explanation for the
pathogenesis of these glomerular disorders.
RESULTS
Distribution of Distinct Subsets of CD133CD24
Renal Progenitors in the Bowman’s Capsule of Adult
Healthy Human Kidneys
We first evaluated the expression of the renal progenitormark-
ers CD133 and CD24 in 15 healthy human kidneys by using
laser confocal microscopy. In adult human glomeruli, coex-
pression of CD24 and CD133 was restricted to renal progeni-
tors (Figure 1A), as described previously.12–16 CD133CD24
renal progenitors also expressed claudin-1 (Figure 1B), caveo-
lin-1, cytokeratin, and vascular cellular adhesion molecule 1
(VCAM-1; data not shown), markers that within the glomer-
ulus are expressed by the parietal epithelial cells (PECs) but not
by podocytes.19–22 On the basis of the expression of renal pro-
genitor markers CD133 and CD24 and of podocyte markers
such as nestin23 or PDX, we confirmed that the cells lining
Bowman’s capsule are arranged in a precise sequence within
the Bowman’s capsule and consist of three distinct populations
of cells, as already reported.16 A subset of more undifferenti-
ated cells expressing CD133 and CD24 in the absence of nestin
and PDX localized to the urinary pole of the Bowman’s capsule
(Figure 1).16 A transitional population (progenitor podocytes)
expressing CD133 and CD24, as well as nestin and PDX, usu-
ally localized between the urinary and the vascular pole (Figure
1).16 Finally, more differentiated cells expressing neither
CD133 nor CD24 but exhibiting the podocyte markers local-
ized at the vascular pole of Bowman’s capsule and were con-
tiguous with differentiated podocytes (Figure 1).16
Distinct Subsets of CD133CD24 Cells Are Major
Constituents of Hyperplastic Lesions in
Podocytopathies
We then evaluated the possible contribution of different pro-
genitor cell subsets aswell as tuft podocytes to the generation of
intraglomerular hyperplastic lesions of patients affected by two
types of podocytopathies, collapsing glomerulopathy, and
FSGS.
Collapsing Glomerulopathy.
In collapsing glomerulopathy, hyperplastic intraglomerular le-
sions consisted of high numbers of cells (range 12 to 59; mean
32.9  12.6) (Figure 2A). Triple-label immunofluorescence
demonstrated that 50 to 75% of total cells represented imma-
ture progenitors, which expressed the renal progenitor mark-
ers CD133 and CD24 but not nestin or PDX (Figure 2). In
addition, tuft podocytes, expressing nestin or PDX in the ab-
sence of CD24 andCD133, represented 10 to 40%of total cells.
Finally, a population representing 2 to 15% of the cells were
CD133CD24nestin, thus exhibiting a transitional pheno-
type and suggesting their nature of progenitor podocytes (Fig-
ure 2B). Similar results were obtained by using PDX instead of
nestin as a podocyte marker (Figure 2C).
Focal Segmental Glomerulosclerosis.
In FSGS, glomeruli showed mild signs of hyperplasia and in-
traglomerular lesions consisted of lower numbers of cells
(range 4 to 23; mean 11.1 6.6). Again, even the FSGS lesions
were mostly represented by CD133CD24nestin cells (55
to 82% of the cells; Figure 2, D through F). In addition, tuft
podocytes, expressing nestin or PDX in the absence of CD24
and CD133, represented 6 to 30% of total cells. Finally, 5 to
25% of the cells were CD133CD24nestin, thus represent-
ing progenitor podocytes (Figure 2E). Similar results were ob-
tained when PDX was used as a podocyte marker instead of
nestin (data not shown).
In agreement with previous results, the CD133CD24 re-
nal progenitors within the lesion of both collapsing glomeru-
lopathy and FSGS were also characterized by coexpression
with the PECs markers claudin-1 (Figure 2F), cytokeratin,
caveolin-1, and VCAM-1 (data not shown). Only rare cells of
the lesions expressed -smooth muscle actin (-SMA; a
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marker for activatedmesangium andmyofibroblasts) or CD68
(amarker formonocytes/macrophages), but these cells did not
coexpress CD133 or CD24 (data not shown).
To provide additional evidence in favor of these observations,
we performed quantitative real-time reverse transcriptase–PCR
(RT-PCR) onhyperplastic lesions obtained through laser capture
microdissection of affected glomeruli. As a comparison, we
used identical areas obtained from healthy glomerular tufts,
because in healthy adult human kidneys, the glomerular tuft
does not contain renal progenitors, whereas it contains a high
number of mature podocytes. The hyperplastic lesions ex-
pressed significantly higher levels of the renal progenitor
markers CD133 and CD24 and of the transcription factors
Oct-4 and BmI-1, which are specific for renal progenitors,12 in
comparisonwith healthy glomerular tufts (Figure 2G). By con-
trast, the podocyte markers nestin, podocin, and nephrin were
consistently more expressed in the healthy glomerular tuft in
comparison with hyperplastic lesions (Figure 2H).
CD133CD24 Cells Are Major Constituents of the
Tip Lesion
Glomerular tip lesion has been associatedwith FSGS,minimal-
change nephropathy, membranous nephropathy, diabetic ne-
phropathy, and postinfectious glomerulonephritis, which sug-
gests that it does not represent a specific disease; however, this
lesion consists of a collection of cells localized at the urinary
pole of the Bowman’s capsule, suggesting a possible involve-
ment of CD133CD24 renal progenitors in its generation. In
our study, a tip lesion consisted of 16.9  8.4 (range 6 to 23)
cells. Most of these cells were positive for CD24 and CD133
(Figure 3, A and B). In particular, 60 to 85% of total cells were
CD133CD24nestin, whereas 8 to 16% of the cells were
CD133CD24nestin (progenitor podocytes). Tuft podo-
cytes represented 5 to 20% of total cells. Similar results were
obtained when PDX was used as a podocyte marker instead of
nestin (Figure 3C). Finally, quantitative real-time RT-PCR
performed on hyperplastic lesions obtained through laser cap-
Figure 1. Assessment of CD24 and
CD133 expression in normal human
kidney is shown. (A) Both CD24 and
CD133 are, within the glomerular
structure, exclusively expressed by
the epithelial cells lining the Bow-
man’s capsule in adult human glo-
meruli. NHK, normal human kidney.
(B) CD24CD133 renal progeni-
tors also expressed claudin-1 (blue).
(C) Double-label immunofluores-
cence for CD133 (green) and nestin
(red) demonstrating the existence
of cells expressing CD133 in ab-
sence of the podocyte marker nes-
tin, which localize to the urinary
pole (UP) of the Bowman’s capsule,
and cells expressing CD133 and
nestin, which localize between the
UP and the vascular pole (VP) of the
Bowman’s capsule (arrow). Glomer-
ular podocytes also appear as
CD133nestin. To-pro-3 counter-
stains nuclei. (D) Double-label im-
munofluorescence for CD133 (green)
and PDX (red) demonstrating the
existence of cells expressing
CD133, which localize to the UP of
the Bowman’s capsule, and cells ex-
pressing CD133 and PDX (arrows),
which localize between the UP and
the VP of the Bowman’s capsule.
Glomerular podocytes also appear
as CD133PDX. To-pro-3 counter-
stains nuclei. (D) High magnifica-
tion of the UP. Arrow points to cells
showing double labeling for CD133
and PDX. To-pro-3 counterstains nuclei. (D) High magnification of the VP. Arrow points to cells showing double labeling for CD133 and
PDX. To-pro-3 counterstains nuclei. Magnifications: 400 in A through C; 200 in D; and 560 in D and D.
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ture microdissection of affected glomeruli confirmed that also
in the tip lesions CD133, CD24, Oct-4, and BmI-1 are consis-
tently more expressed in comparison with healthy glomerular
tufts (Figure 3D). By contrast, nestin, podocin, and nephrin
weremore expressed in the healthy glomerular tuft in compar-
ison with the tip lesions (Figure 3E).
Distinct Subsets of CD133CD24 Cells Are Major
Constituents of Hyperplastic Lesions in Crescentic
Glomerulonephritis
In crescentic glomerulonephritis, hyperplastic lesions con-
sisted of 35.9  11.3 (range 9 to 53) cells. In the lesions ana-
lyzed, 45 to 80% of total cells were CD133CD24nestin. In
addition, CD133CD24nestin cells (tuft podocytes) were 5 to
50% of total cells in hyperplastic lesions, whereas a population
representing 3 to 18% of the cells were CD133CD24nestin
(progenitor podocytes), thus exhibiting a transitional phenotype
(Figure 4, A andC). Similar results were obtainedwhen PDXwas
used as a podocyte marker instead of nestin (Figure 4B).
CD133CD24 cells within the crescents and along Bowman’s
capsulewere also characterizedby coexpressionof claudin-1 (Fig-
ure 4D), caveolin-1 (Figure 4E), cytokeratin, and VCAM-1 (data
not shown). Only rare cells of the lesions expressed -SMA (data
not shown). UsingCD68 as amacrophagemarker, we found that
the majority of cases of crescentic glomerulonephritis have
CD68 cells in crescents, although these cells were rare in the
“early”cellular crescentsanalyzed(Figure4F).Double labeling for
CD133 orCD24 andCD68or-SMA showedno cells coexpress-
ing these two antigens (data not shown). To provide further sup-
port to these results, we analyzed themRNA levels of CD133 and
CD24 of the renal progenitor–specific transcription factorsOct-4
and BmI-1 and of the podocyte markers nestin, podocin, and
nephrin. Quantitative real-time RT-PCR performed on hyper-
plastic lesions obtained through laser capture microdissection
from the kidneys of patients with crescentic glomerulonephritis
demonstrated that these latter expressed significantlyhigher levels
Figure 2. Phenotypic analysis of the cells involved in hyperplastic lesions of podocytopathies is shown. (A) Assessment of CD24 and
CD133 expression in kidneys with collapsing glomerulopathy. The involved epithelial cells were positive for both CD24 and CD133
(arrow). (B) In collapsing glomerulopathy, the involved epithelial cells were positive for both CD24 (red) and nestin (green). Merged
images are in yellow (arrow). (B) High magnification of the lesion in collapsing glomerulopathy. (C) Assessment of the co-localization
among CD24, CD133, and PDX. In collapsing glomerulopathy lesions, the involved epithelial cells were positive for both CD24 (red)
and CD133 (green). Merged images are in yellow. Rare cells within the lesion exhibited a triple labeling for PDX (blue), CD133, and
CD24 (arrows). Merged images are in white. (C) High magnification of collapsing glomerulopathy lesion. (D) Assessment of CD24 and
CD133 expression in kidneys with FSGS. The involved epithelial cells were positive for both CD24 (green) and CD133 (red). Merged
images are in yellow (arrow). (E) Assessment of the co-localization among CD24, PDX, and nestin. In FSGS lesions, the involved
epithelial cells were mostly positive for CD24 (red) but negative for PDX (blue) or nestin (green). Rare cells within the lesion exhibiting
a triple labeling for CD24, PDX, and nestin are also visible (white). (E) High magnification of a FSGS lesion. (F) Assessment of the
co-localization between the progenitor markers CD24 (green) and CD133 (red) and the PEC marker claudin-1 (blue) in a biopsy showing
FSGS with mild hyperplasia. All markers were expressed by the epithelial cells lining the Bowman’s capsule and the cells involved in
the lesion (arrow). (F) High magnification of FSGS lesion. (G and H) CD133, CD24, Oct-4, BmI-1, nestin, podocin, and nephrin mRNA
quantification in identical areas of hyperplastic lesions of different podocytopathies and healthy glomerular tuft as obtained with laser
capture microdissection. Data are means  SEM of five independent experiments. Magnifications: 200 in D; 400 in A, B, B, C, C,
E, F, and F; and 600 in E.
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of CD133 and CD24, Oct-4, and BmI-1 in comparison with
healthy glomerular tufts (Figure 4G). By contrast, the podocyte
markers nestin, podocin, and nephrinwere consistentlymore ex-
pressed in the healthy glomerular tuft in comparison with the
crescentic lesion (Figure 4H).
Proliferating Cells in Podocytopathies and Crescentic
Glomerulonephritis Are CD133CD24
To evaluate which cells contributed to the generation of hyper-
plastic lesions through their proliferation, we evaluated the
expression of the proliferation marker Ki67 in combination
withCD133, CD24, PDX, and nestin. Triple-label immunoflu-
orescence demonstrated that proliferating epithelial cells in
collapsing glomerulopathy and crescentic glomerulonephritis
mostly expressed CD133 and CD24 in the absence of podocyte
markers, such as PDX and even nestin (Figure 5). Interestingly,
however, a relevant subset of proliferating cells consisted of a
transitional population of cells (progenitor podocytes) coex-
pressing not only the progenitor markers CD133 and CD24
but also the podocyte markers nestin and PDX (Figure 5). Fi-
nally, Ki67 was virtually never observed on cells (tuft podo-
cytes) that expressed nestin and PDX in the absence of CD133
and CD24 (Figure 5). Although the number of proliferating
cells was consistently lower in FSGS, CD133CD24nestin
(renal progenitors) and CD133CD24nestin (progenitor
podocytes) were the only cells to show proliferative potential.
Results for podocytopathies and crescentic glomerulonephritis
are quantified in Figure 5, A and C. Similar results were ob-
served also in the tip lesions (data not shown).
Cultured CD133CD24 Renal Progenitors Produce ECM
Components in Response to TGF- Treatment.
Progression of glomerular injury toward glomerulosclerosis is
characterized by the evolution from an early cellular glomeru-
lar lesion to a fibrous lesion, which is related to progressive
accumulation of ECM.24,25 TGF- is the major determinant of
the matrix accumulation26–30; therefore, to evaluate whether
renal progenitors can also produce and deposit the ECM in
response to TGF-, we analyzed the effects of TGF- treat-
ment on the production of 1 and 3 chain of collagen IV,
the 1 chain of collagen I, fibronectin, and laminin by renal
progenitors in comparison with podocytes. To obtain podo-
cytes (CD133CD24PDX), in the absence of cells with a
transitional phenotype (CD133CD24PDX), we recov-
ered CD133CD24PDX podocytes by immunomagnetic
separation or directly from cultured glomeruli after com-
plete digestion of the Bowman’s capsule, as reported in the
Concise Methods section. Treatment of renal progenitors
with TGF- resulted in a markedly increased expression of
all ECM molecules tested at different time points, as as-
Figure 3. Phenotypic analysis of the cells involved in the generation of the tip lesion is shown. (A) Assessment of CD24 and CD133
expression in kidneys with tip lesion. The involved epithelial cells were positive for both CD24 and CD133 (white arrows). Black arrows
indicate the tip lesion. (B) Assessment of the co-localization among CD24, CD133, and nestin in a tip lesion. The involved epithelial cells
were positive for both CD24 (green) and CD133 (red). Merged images are in yellow (arrow). (B) High magnification of the lesion. (C)
Assessment of the co-localization among CD24 (red), CD133 (green), and PDX (blue) in a tip lesion. Rare cells exhibited a triple labeling
for CD133, CD24, and PDX (arrows). Merged images are in white. (C) High magnification of the lesion. The image was rotated to show
the triple-labeled cells better. (D and E) CD133, CD24, Oct-4, BmI-1, nestin, podocin, and nephrin mRNA quantification in identical
areas of tip lesions or healthy glomerular tuft as obtained with laser capture microdissection. Data are means SEM of five independent
experiments. Magnifications: 400 in A, B, B, and C; and 600 in C.
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sessed by real-time quantitative RT-PCR (Figure 6). By con-
trast, podocytes showed only a slight increase of the 3
chain of collagen IV and of fibronectin after TGF- treat-
ment.
DISCUSSION
Until now, theories explaining the origin of aberrant epithelial
cells in collapsing glomerulopathy and crescentic glomerulo-
nephritis have been controversial.5,31–43 One possibility is that
these cells are exclusively of parietal epithelial origin,34,38,40,42
whereas others suggested that some dedifferentiated podocytes
acquire markers of PECs5,31,32,35,36,39,41; however, more recent
studies demonstrated that the intermediate filament protein
nestin, which is specifically expressed during any stage of
podocyte development and in the mature cell, may allow the
investigation of podocyte involvement in glomerular disor-
ders.23,43
In this study, we hypothesized that hyperplastic epithelial
cells of human glomerulopathies might derive from the two
distinct populations of CD133CD24 renal progenitors res-
ident in the Bowman’s capsule of the adult human kidney:
More undifferentiated progenitors lacking podocyte markers
(CD133CD24PDXnestin) and transitional cells (pro-
genitor podocytes) that additionally express podocytemarkers
(CD133CD24PDXnestin).16 Studies in mice have docu-
mented that these progenitors are responsible for podocyte
replacement,17 consistent with the human findings reported
here showing the presence of progenitor cells in disease condi-
tions characterized by podocyte loss.
In all glomerular diseases under consideration here, com-
bined findings by confocal microscopy, laser capture micro-
dissection, and real-time quantitative RT-PCR showed that
the most represented cells of hyperplastic lesions are
CD133CD24PDXnestin progenitors, and transitional
cells (progenitor podocytes) are also present. Interestingly, a
consistent amount of podocytes were found in the lesions.
Moreover, virtually all of the proliferating cells (Ki67) ex-
pressed the renal progenitor markers, with or without nestin.
Accordingly, Bariety et al.44 demonstrated the existence within
the Bowman’s capsule of a population of “parietal podocytes,”
which coexpress markers of podocytes and parietal epithelium
while maintaining the ability to proliferate.44 Thus, from our
Figure 4. Phenotypic analysis of the cells involved in hyperplastic lesions of crescentic glomerulonephritis is shown. (A) Assessment
of the co-localization among CD24, CD133, and nestin. In crescents, the involved epithelial cells were positive for both CD24 (red) and
CD133 (green). Merged images are in yellow. Rare hyperplastic cells exhibited a triple labeling for CD133, CD24, and nestin (blue).
Merged images are in white. (A) High magnification of the hyperplastic lesion. (B) Assessment of the co-localization among CD24,
CD133, and PDX. In crescents, the involved epithelial cells were positive for both CD24 (red) and CD133 (green). Merged images are
in yellow. Rare hyperplastic cells exhibited a triple labeling for CD133, CD24, and PDX (blue). Merged images are in white. (B) High
magnification of the hyperplastic lesion. (C) Assessment of the co-localization among CD24 (red), PDX (blue), and nestin (green). In
crescents, the involved epithelial cells were mostly positive for CD24 but negative for PDX or nestin. Rare hyperplastic cells exhibited
a triple labeling for CD24, PDX, and nestin. Merged images are in white. (C) High magnification of the hyperplastic lesion. (D and E)
Assessment of the co-localization between the progenitor cell markers CD24 (green) and CD133 (red) and the PEC markers claudin-1
(D, blue) and caveolin-1 (E, blue). All four markers were expressed by the epithelial cells lining the Bowman’s capsule and the proliferative cells
involved in the lesions. A great overlap was observed in the staining pattern of the three markers (white). (D and E) High magnification of
the hyperplastic lesion. (F) Absence of co-localization between CD24 (red) and CD68 (green) in hyperplastic lesions. Arrow points to CD68
cells within the lesion. (G and H) CD133, CD24, Oct-4, BmI-1, nestin, podocin, and nephrin mRNA quantification in identical areas of
hyperplastic lesions of crescentic glomerulonephritis or healthy glomerular tuft as obtained with laser capture microdissection. Data are
means  SEM of four independent experiments. Magnifications: 400 in A, A, B, C, and F; 200 in C, D, D, E, and E; and 600 in B.
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data, immature progenitors (nestin) or podocyte progenitors
(transitional cells nestin) all express markers of proliferation
in contrast with differentiated podocytes that do not express
proliferation markers (Ki67). Whether these differentiated
podocytes are native to the tuft or derive from progenitors
cannot be established. These findings also provide a possible
explanation for the results observed in some transgenic mouse
models in which tagged podocytes actively proliferate within
hyperplastic lesions.23,32,33 Indeed, because both podocytes of
the tuft and podocyte progenitors of the Bowman’s capsule
express podocyte markers, albeit at different levels,17 they
might be tagged using a podocyte-specific promoter. Alterna-
tively, different results might also be explained by the distinct
experimental systems used. Indeed, it is likely that more than
one mechanism leads to the samemorphologic damage. Thus,
glomerular abnormalities reflect patterns of injury rather than
diseases.
One major observation in this article is that renal progeni-
tors of hyperplastic lesions display diverse proliferative re-
sponse in different diseases. This greatly helps in identifying
relevant pathways that initiate or influence intraglomerular
cell proliferation/differentiation. Interestingly, Le Hir et al.45
demonstrated that crescents in proliferative glomerulonephri-
tis develop at cell bridges between podocytes and PECs that
disrupt epithelial cell polarity.45 Our data suggest that in cres-
centic glomerulonephritis, attachment of podocytes to PECs
and/or disruption of progenitor cell polarity initiates an ab-
normal proliferation of progenitors,11 resulting in crescentic
disease. Given the strict similarity in numbers of proliferating
progenitors, this concept may be applied to collapsing glo-
merulopathy. Indeed, in mice that express the Thy-1.1 antigen
on podocytes, injection of anti–Thy-1.1 mAb induces a mas-
sive podocyte injury, with acute albuminuria and collapse of
glomerular tuft, prominent extracapillary proliferation, and
frequent attachments of hypertrophic podocytes to Bowman’s
capsule as seen in collapsing glomerulopathy.42
A related process would explain the generation of the tip
lesion, that, according to some authors, has been categorized as
a transcategorical entity, observed at the urinary pole.9,46 Here,
CD133CD24PDXnestin progenitors were again the
main constituent of hyperplastic lesions. As previously re-
ported, the replacement of podocytes in the tuft follows a gra-
dient, with novel podocytes being progressively added from
the vascular stalk.16,17 Because the tip podocytes represent the
“oldest” podocytes of the tuft, theymight be the first to die and
thus to be replaced by renal progenitors at sites of attachment
at the urinary pole. Interestingly, the tip lesion occurs in several
proteinuric conditions, including podocytopathies, membra-
nous nephropathy (where it is present in 64% of cases),46
postinfectious glomerulonephritis,47 and diabetic nephropa-
thy.48 On this basis, Haas et al.49 argued that the tip lesion is a
response to prolonged heavy proteinuria. Consistently, exper-
imental evidence in vitro and inmodels of disease documented
that the exposure of podocytes to excessive amounts of plasma
proteins promotes podocyte dysfunction and injury followed
by tuft adhesion and sclerosis.50,51
The key finding in FSGS was a less prominent proliferation
of CD133CD24 progenitors despite their comparable per-
Figure 5. Proliferating cells in hy-
perplastic glomerular lesions de-
rive from CD133CD24nestin
and CD133CD24nestin cells. (A)
Quantification of the percentages
of CD133CD24nestin (range 50
to 81%), CD133CD24nestin
(range 5 to 46%) and CD133-
CD24nestin cells (range 0 to 3%)
over the total of Ki67 cells in hy-
perplastic lesions of podocytopa-
thies. (B) A representative image
showing triple-label immunofluo-
rescence for CD24 (red), PDX (blue),
and Ki67 (green), demonstrating
that proliferating epithelial cells in a
glomerulus of a patient with col-
lapsing glomerulopathy express
CD24 in absence of PDX or coex-
press CD24 and PDX. No PDX but
CD24 cells express Ki67. (B) High
magnification of the lesion. (C) Quantification of the percentages of CD133CD24nestin (range 48 to 90%), CD133CD24nestin
(range 3 to 42%), and CD133CD24nestin cells (range 0 to 3%) over the total of Ki67 cells in a glomerulus of a patient with
crescentic glomerulonephritis (GN). (D) Representative image showing triple-label immunofluorescence for CD24 (red), PDX (blue), and
Ki67 (green), demonstrating that proliferating epithelial cells in crescentic glomerulonephritis express CD24 in the absence of PDX or
coexpress CD24 and PDX. No PDX but CD24 cells express Ki67. (D) High magnification of the lesion. Magnification: 400 in B, D, and
D; and 600 in B.
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centage in respect to those found in crescentic disease or other
podocytopathies, suggesting that FSGSwould be at leastmark-
edly accelerated by an insufficient proliferation of resident
progenitors to replace injured podocytes, resulting in release of
ECM and generation of scar. That this could be the case is
indicated by our in vitro finding of production and deposition
of high amounts of ECM by CD133CD24PDX progeni-
tors exposed to TGF-, which is also highly secreted by podo-
cytes in response to proteinuria.50 In contrast, an abnormally
high regenerative activity by resident renal progenitors would
result in hyperplasia, similar to the hypertrophic scarring ob-
served in skin keloids. Reasons underlying this different re-
sponse might be related to the type of injury or to the different
genetic backgroundof patients, as suggested by a recent study52
demonstrating that induction of a podocyte damage leads to
glomerular injury with segmental lesions and mild intraglo-
merular proliferation of PECs in wild-type mice but to a com-
plete histologic pattern of collapsing glomerulopathy related to
high PECs proliferation in mice knockout for the cell cycle
inhibitor p21.
Finally, the evolution of the hyperplastic lesion is likely to be
dependent also on the severity of podocyte injury. Data previ-
ously reported by Wiggins et al.3 suggested that remission can
occur as long as 20% of podocytes are lost. Accordingly,
results in transgenicmice support the ability of PECs to replace
approximately 10% of adult podocytes during adolescence.17
By contrast, 20 to 40% podocyte depletion results in scarring,
and when podocyte depletion is 60%, the glomerulus dies
and the nephron is lost.3 On the basis of the results of this and
previous studies, we suggest that podocytopathies can undergo
remission because of replacement of injured podocytes by the
Bowman’s capsule progenitors, suggesting the potential use of
renal progenitors for the treatment of patients with FSGS.16,53
Taken together, these results provide a newpoint of view for
the pathogenesis of different types of podocytopathies and
crescentic glomerulonephritis and allow us to suggest renal
progenitors of the Bowman’s capsule as a novel potential target
for the setup of therapies for glomerular disorders.53
CONCISE METHODS
Patients
We studied a total of 43 tissue specimens from patients with various
types of glomerular disorders. To address the possible participation of
renal progenitors to the response to podocyte injury, we analyzed
biopsies with mild to severe degree of intraglomerular proliferation.
In particular, on the basis of the taxonomy by Barisoni et al.,9,10 we
Figure 6. Differential upregulation of ECM components after treatment with TGF- in CD133CD24 renal progenitors and
podocytes. (A and B) Double-label immunofluorescence for CD133 (red) and WT-1 (green) on podocytes (A) and on CD133CD24
renal progenitors (B). To-pro-3 counterstains nuclei (blue). (C, E, G, and I) Assessment of mRNA levels for collagen 3(IV) and collagen
1(IV) (C), collagen 1(I) (E), fibronectin (G), and laminin (I) by real-time quantitative RT-PCR in podocytes treated with 5 ng/ml TGF-.
(D, F, H, and J) Assessment of mRNA levels for collagen 3(IV) and collagen 1(IV) (D), collagen 1(I) (F), fibronectin (H), and laminin
(J) by real-time quantitative RT-PCR in CD133CD24 renal progenitors treated with 5 ng/ml TGF-. Data are means  SEM of
triplicate assessment from three different experiments. *P  0.05. Magnification, 200 in A and B.
BASIC RESEARCH www.jasn.org
2600 Journal of the American Society of Nephrology J Am Soc Nephrol 20: 2593–2603, 2009
analyzed kidney specimens of 13 patients with two different types of
podocytopathies: Collapsing glomerulopathy (n	 6) and FSGS (n	
7). Among podocytopathies, collapsing glomerulopathy and FSGS
were selected because they represent the extremepossible responses to
podocyte injury. Indeed, collapsing glomerulopathy is characterized
by high intraglomerular epithelial hyperplasia, whereas FSGS is char-
acterized by podocyte detachment/death leading to podocytopenia,
often associated with a mild degree of intraglomerular hyperplasia
and segmental sclerosis.9,10 In addition, we analyzed biopsies from
patients with a tip lesion (n	 5).Whereas collapsing glomerulopathy
and FSGS are included in the proposed taxonomy,9,10 the tip lesion,
according to some authors,9,46,49 has been categorized as a transcat-
egorical entity. The tip lesion was included in our study because it
consists of a collection of cells localized at the urinary pole of the
Bowman’s capsule, thereby suggesting a possible involvement of
CD133CD24 renal progenitors in its generation. In addition, we
studied kidney biopsy specimens of 25 patients who had crescentic
glomerulonephritis. The histologic diagnosis was IgA nephropathy
(n	 8), ANCA glomerulonephritis (n	 9), lupus nephritis (n	 4),
and Scho¨nlein-Henoch disease (n	 4). The patients were selected on
the existence of extracapillary proliferation in sections of the cryo-
specimens. In addition, macroscopically normal portions of renal tis-
sue were obtained from 15 patients undergoing nephrectomy because
of renal cell carcinoma, in accordance with the recommendations of
the ethical committee of the Azienda Ospedaliero-Universitaria Car-
eggi, Florence, on human experimentation.
Immunofluorescence and Confocal Microscopy
Weperformed double labelings for CD24 andCD133. In addition, we
stained for bothmarkers separately on serial sections.We assessed the
localization of the hyperplastic lesions in periodic acid Schiff–stained
sections and made a comparison with the localization of CD24 and
CD133 cells in immunostained consecutive sections. Two-micro-
meter acetone-fixed cryosections were incubated with antibodies
against CD24 (clone SN3; SantaCruz Biotechnology, SantaCruz, CA)
or against CD133 (CD133/1 clone AC133; Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany). The primary antibodies were detected
with goat anti-mouse IgG1-Alexa 488 (Molecular Probes, Leiden,
Netherlands). For double labeling, the sections were incubated with
anti-CD24 and subsequently with anti-CD133 (CD133/2 clone
293C3; Miltenyi Biotec GmbH). The primary antibodies were de-
tected with goat anti-mouse IgG1-Alexa 488 and goat anti-mouse
IgG2b-Alexa 546 (Molecular Probes). In control sections, primary
antibodies were omitted. The sections were examined using a fluores-
cence microscope (Leica Microsystems GmbH, Wetzlar, Germany).
Digital images were made at exactly the same positions within the
consecutive section and automatically overlaid using the Leica
CW4000 CytoFISH software (Leica Microsystems, GmbH) to obtain
the merged image.
Confocal microscopy was performed on 5-m sections of renal
frozen tissues or on cell cultures by using a LSM 510 META laser
confocal microscope (Carl Zeiss, Jena, Germany), as described previ-
ously.12–14
The double immunolabeling was performed by using the follow-
ing primary antibodies: CD133 (clone 293C3)/Nestin (Chemicon,
Temecula, CA), CD133 (clone 293C3)/PDX (222328; R&D Systems,
Minneapolis, MN), CD24/CD68 (EBM11; Dako, Glostrup, Den-
mark), and CD133 (clone 293C3)/WT-1 (F6; Santa Cruz Biotechnol-
ogy). The secondary appropriate antibodies were the following: Goat
anti-mouse IgG2b-Alexa 488, goat anti-rabbit IgG-546, goat anti-
mouse IgG2a-Alexa 546, goat anti-mouse IgG1–546 and goat anti-
rabbit IgG-488 (Molecular Probes). The triple immunolabeling was
performed by using the following primary antibodies: CD133 (clone
293C3)/CD24/nestin, CD133 (clone 293C3)/CD24/PDX, CD24/
PDX/nestin, CD24/CD133 (clone 293C3)/claudin-1 (ab15098; Ab-
cam, Cambridge, UK), CD24/CD133 (clone 293C3)/caveolin-1
(clone N20; Santa Cruz Biotechnology), and CD24/PDX/Ki67 (pAb;
Abcam, Cambridge, UK). The secondary appropriate antibodies were
the following: Goat anti-mouse IgG2b-Alexa 488 or -546, goat anti-
mouse IgG1–546 or -488, and goat anti-rabbit IgG-633 or -488 (Mo-
lecular Probes). For each adult normal renal sample, two independent
observers assessed all of the glomerular sections for all of themarkers.
Twenty randomly selected glomeruli were assessed from at least
three sections from each patient to quantify the percentage of
CD133CD24nestin, CD133CD24nestin, and CD133-
CD24nestin cells over the total number of cells of the lesion or over
the total number of Ki67 cells in hyperplastic lesions of all of the
glomerulopathies analyzed.
Laser Capture Microdissection and Real-Time
Quantitative RT-PCR
Frozen renal specimens were subjected to laser capture microdissec-
tion as described previously.54 Areas with identical proportions
(mean area 50,000 m2) of glomerular hyperplastic lesions and
healthy glomerular tufts were dissected from sections of biopsies or
normal tissue specimens, respectively. Microdissected tissue areas
were collected for RNA extraction using the RNeasy Micro kit (Qia-
gen, Hilden, Germany). Samples were used for TaqMan real-time
RT-PCR analysis according to previously described protocols.55
CD133, CD24, BmI-1, nestin, podocin, and nephrin quantification
was performed using primers and probes fromAssay on Demand kits
(Applied Biosystems,Warrington,UK). Primers and probes forOct-4
were described previously.12 Collagen 3 (IV), collagen 1 (IV), col-
lagen 1 (I), laminin, fibronectin, and glyceraldehyde-3-phosphate
dehydrogenase quantification was performed using Assay on De-
mand kits (Applied Biosystems) after stimulation of cells with 5 ng/ml
TGF-. Messenger RNA levels were quantitatively analyzed by com-
paring experimental levels with standard curves generated with serial
dilutions of the same positive sample. Taq-Man RT-PCR was per-
formed as described previously.55
Cell Cultures
To recover CD133CD24 cells and CD133CD24PDX cells
(podocytes), we first depleted total renal cells for CD45 andCD31 and
then labeled them with PE-conjugated anti-PDX mAb (R&D Sys-
tems), followed by magnetic labeling with anti-PE Multisort mi-
crobeads using the anti-PEMultisort Kit (Miltenyi), as described pre-
viously.16 To obtain podocytes, we removed magnetic beads by using
Multisort release reagent and PDX cells treated with a second mag-
netic separation for CD133 (CD133 Cell Isolation Kit; Miltenyi). By
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contrast, to obtain CD133CD24 cells, we directly treated total re-
nal cells depleted for CD45 and CD31 with a magnetic separation for
CD133. The purified cell fractions consisted of 98% of
CD133CD24 or CD133CD24PDX cells. Alternatively, podo-
cytes were obtained from cultured glomeruli after complete digestion
of the Bowman’s capsule, as described previously.56 Expression of
WT1, nephrin, and CD133 was checked to evaluate the purity of
podocyte cultures obtained through glomerular outgrowth. Cells
were cultured as described previously.16
Statistical Analysis
The results are expressed as means  SEM. Comparison between
groups was performed by the Mann-Whitney test or the Wilcoxon
test, as appropriate. P 0.05 was considered to be statistically signif-
icant.
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